Clinical Trial: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment for 12 Weeks in Adolescent and Adult Patie

Brief Summary: The study will compare the efficacy and safety of brivaracetam with placebo in patients with Unverricht-Lundborg disease.